New Threat for GlaxoSmithKline: Avandia Spammers (GSK)
GlaxoSmithKline (GSK-NYSE) has been under significant pressure of late because of the New England Journal of Medicine showing greatly increased risks of a heart attack for diabetes patients that have taken AVANDIA. …